多肽纳米盘抑制乳腺癌迁移的体外研究
Inhibitory Effect of Peptide Nanodiscs on Breast Cancer Migration In Vitro
DOI: 10.12677/ACM.2020.1011394, PDF,    国家自然科学基金支持
作者: 卢光照, 高习清, 张 翮, 邹 豪, 鲁 莹*:中国人民解放军海军军医大学药学系药剂学教研室,上海;于永生:同济大学上海市第一妇婴保健院,上海;高 洁:上海大学生物材料和再生医学中心,上海;王彦峰:火箭军特色医学中心药剂科,北京
关键词: 多肽纳米盘乳腺癌迁移Peptides Nanodiscs Breast Cancer Migration
摘要: 目的:乳腺癌发生转移是患者死亡的主要原因。我们前期研发了具有良好抑制肿瘤细胞迁移的多肽。然而多肽在体内降解快,不稳定,影响药效。因此,亟需一种方法来降低多肽降解速率。方法:采用脂质纳米盘包裹多肽可以保护多肽,提高多肽稳定性。结果:本文成功构建了多肽纳米盘,纳米盘粒径为16.36 ± 0.37 nm,PDI为0.387 ± 0.039,粒径均匀。多肽的包封率为80.86% ± 0.77%,载药量为1.43% ± 0.01%。多肽对MDA-MB-231细胞没有细胞杀伤作用,空白纳米盘对MDA-MB-231细胞有显著杀伤效果,IC50为262.6 ug/ml。多肽能够显著抑制MDA-MB-231细胞的细胞迁移,在一定浓度范围,多肽浓度越高,抑制作用越强。结论:多肽纳米盘在体外能够显著抑制乳腺癌细胞转移,为转移性乳腺癌治疗提供新方法。
Abstract: Objective: Breast cancer metastasis is the main cause of death. We have developed a peptide with good inhibition of tumor cell migration. However, the degradation of peptides in vivo is fast and unstable, which affects the efficacy of drugs. Therefore, there is an urgent need for a method to reduce the degradation rate of peptides. Methods: The peptide coated with lipid nanoparticles can protect the peptide and improve the stability of the peptide. Results: In this paper, peptide nanodiscs were successfully constructed. The diameter of nanodiscs was 16.36 ± 0.37 nm, and the PDI was 0.387 ± 0.039. The encapsulation efficiency was 80.86% ± 0.77%, and the drug loading was 1.43% ± 0.01%. The peptide had no cytotoxic effect on MDA-MB-231 cells, while blank nanodiscs had a significant killing effect on MDA-MB-231 cells with IC50 of 262.6 ug/ml. The polypeptide could significantly inhibit the migration of MDA-MB-231 cells. In a certain concentration range, the higher the peptide concentration, the stronger the inhibition effect. Conclusion: Peptide can significantly inhibit the migration of breast cancer cells in vitro, which provides a new method for the treatment of metastatic breast cancer.
文章引用:卢光照, 高习清, 张翮, 于永生, 高洁, 王彦峰, 邹豪, 鲁莹. 多肽纳米盘抑制乳腺癌迁移的体外研究[J]. 临床医学进展, 2020, 10(11): 2599-2604. https://doi.org/10.12677/ACM.2020.1011394

参考文献

[1] Edwards, B.K., Ward, E., Kohler, B.A., et al. (2010) Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates. Cancer, 116, 544-573. [Google Scholar] [CrossRef] [PubMed]
[2] Hassanpour, S.H. and Dehghani, M. (2017) Review of Cancer from Perspective of Molecular. Journal of Cancer Research and Practice, 4, 127-129. [Google Scholar] [CrossRef
[3] 黄育北, 佟仲生, 陈可欣, 等. 《中国女性乳腺癌筛查指南》解读(精简版) [J]. 中国肿瘤临床, 2019, 46(9): 432-440.
[4] 赵慧朵, 程旭锋, 楚爱景. 疏肝健脾益肾汤联合化疗治疗转移性三阴性乳腺癌患者的临床价值分析[J]. 四川解剖学杂志, 2020, 28(1): 81-82.
[5] 张佳佳. 多西他赛联合希罗达治疗转移性乳腺癌的临床效果分析[J]. 中国医药指南, 2020, 18(7): 125-126.
[6] Yongsheng, Y., Yunyu, N., Qian, F., et al. (2017) Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells. Molecular Pharmacology, 14, 1548-1557. [Google Scholar] [CrossRef] [PubMed]
[7] Liu, J., Qu, J., Zhou, W., et al. (2018) Syntenin-Targeted Peptide Blocker Inhibits Progression of Cancer Cells. European Journal of Medicinal Chemistry, 154, 354-366. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, W., Sun, J., Liu, Y., et al. (2014) PEG-Stabilized Bilayer Nanodisks as Carriers for Doxorubicin Delivery. Molecular Pharmacology, 11, 3279-3790. [Google Scholar] [CrossRef] [PubMed]
[9] Kuai, R., Li, D., Chen, Y.E., et al. (2016) High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles. ACS Nano, 10, 3015-3041. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, M., Xie, F., Wen, X., et al. (2017) Therapeutic PEG-Ceramide Nanomicelles Synergize with Salinomycin to Target Both Liver Cancer Cells and Cancer Stem Cells. Nanomedicine, 12, 1025-1042. [Google Scholar] [CrossRef] [PubMed]